{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:53:13Z","timestamp":1755795193336,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,17]]},"DOI":"10.7759\/cureus.90306","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:08:22Z","timestamp":1755446902000},"source":"Crossref","is-referenced-by-count":0,"title":["Olopatadine vs. Rupatadine for Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.7759","author":[{"given":"Abdur","family":"Rehman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namra","family":"Asif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Shuaib","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhat","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Moaviz","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahroz","family":"Ansar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzaib","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulqadir J","family":"Nashwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Treatment of allergic rhinitis","volume":"81","author":"Sur DK","year":"2010","unstructured":"Sur DK, Scandale S. Treatment of allergic rhinitis. Am Fam Physician. 2010, 81:1440-6.","journal-title":"Am Fam Physician"},{"key":"ref2","article-title":"Comparative evaluation of efficacy and safety of rupatadine and olopatadine in patients of allergic rhinitis: an institutional based study","volume":"9","author":"Dnyandeo CU","year":"2020","unstructured":"Dnyandeo CU, Rao AV, Khond SB, Boopathy S. Comparative evaluation of efficacy and safety of rupatadine and olopatadine in patients of allergic rhinitis: an institutional based study.  Int J Life Sci. 2020, 9:26-9.","journal-title":"Int J Life Sci"},{"key":"ref3","article-title":"A comparison of olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis","volume":"13","author":"Patel KD","year":"2024","unstructured":"Patel KD, Chaturvedi S, Sahu P, Chauhan A. A comparison of olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis. Int J Life Sci. 2024, 13:421-4.","journal-title":"Int J Life Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.195901","article-title":"Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: a prospective, randomized, double-blind, parallel group study","volume":"7","author":"Dakhale G","year":"2016","unstructured":"Dakhale G, Tathod Y, Patel S, Pimpalkhute S, Raghute L, Khamkar A. Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: a prospective, randomized, double-blind, parallel group study. J Pharmacol Pharmacother. 2016, 7:171-6. 10.4103\/0976-500X.195901","journal-title":"J Pharmacol Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2023.03.009","article-title":"Efficacy of different oral H1 antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials","volume":"89","author":"Hong D","year":"2023","unstructured":"Hong D, Weng J, Ye M, Liu Y. Efficacy of different oral H1 antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials. Braz J Otorhinolaryngol. 2023, 89:10.1016\/j.bjorl.2023.03.009","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.85958","article-title":"Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: a comparative study of efficacy and safety","volume":"2","author":"Maiti R","year":"2011","unstructured":"Maiti R, Jaida J, Rahman J, Gaddam R, Palani A. Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: a comparative study of efficacy and safety. J Pharmacol Pharmacother. 2011, 2:270-6. 10.4103\/0976-500X.85958","journal-title":"J Pharmacol Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12932\/AP-201220-1019","article-title":"Efficacy and safety of rupatadine fumarate in the treatment of perennial allergic rhinitis: a multicenter, double-blinded, randomized, placebo-controlled, bridging study in Koreans","volume":"42","author":"Won TB","year":"2024","unstructured":"Won TB, Kim HG, Kim JW, et al.. Efficacy and safety of rupatadine fumarate in the treatment of perennial allergic rhinitis: a multicenter, double-blinded, randomized, placebo-controlled, bridging study in Koreans. Asian Pac J Allergy Immunol. 2024, 42:346-53. 10.12932\/AP-201220-1019","journal-title":"Asian Pac J Allergy Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","article-title":"Appendix: Jadad scale for reporting randomized controlled trials","unstructured":"Appendix. Jadad scale for reporting randomized controlled trials. Evidence\u2010Based Obstetric Anesthesia. Halpern SH, Douglas MJ (ed): Blackwell Publishing Ltd, Oxford, UK; 237-8. 10.1002\/9780470988343.app1","DOI":"10.1002\/9780470988343.app1"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03381.x","article-title":"The minimal clinically important difference in allergic rhinitis","volume":"40","author":"Barnes ML","year":"2010","unstructured":"Barnes ML, Vaidyanathan S, Williamson PA, Lipworth BJ. The minimal clinically important difference in allergic rhinitis. Clin Exp Allergy. 2010, 40:242-50. 10.1111\/j.1365-2222.2009.03381.x","journal-title":"Clin Exp Allergy"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2010.31.3355","article-title":"Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study","volume":"31","author":"Yamamoto H","year":"2010","unstructured":"Yamamoto H, Yamada T, Kubo S, et al.. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study. Allergy Asthma Proc. 2010, 31:296-303. 10.2500\/aap.2010.31.3355","journal-title":"Allergy Asthma Proc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2200165","article-title":"Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine\/mometasone furoate","volume":"19","author":"Ridolo E","year":"2023","unstructured":"Ridolo E, Barone A, Nicoletta F, Paoletti G, Heffler E, Malvezzi L, Canonica GW. Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine\/mometasone furoate. Expert Rev Clin Immunol. 2023, 19:575-84. 10.1080\/1744666X.2023.2200165","journal-title":"Expert Rev Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-023-00282-5","article-title":"Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis","volume":"33","author":"Klimek L","year":"2024","unstructured":"Klimek L, Klimek F, Bergmann C, Hagemann J, Cuevas M, Becker S. Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis. Allergo J Int. 2024, 33:9-19. 10.1007\/s40629-023-00282-5","journal-title":"Allergo J Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.7.14.1989","article-title":"Rupatadine: pharmacological profile and its use in the treatment of allergic disorders","volume":"7","author":"Picado C","year":"2006","unstructured":"Picado C. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders. Expert Opin Pharmacother. 2006, 7:1989-2001. 10.1517\/14656566.7.14.1989","journal-title":"Expert Opin Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2018.08.011","article-title":"Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: a double-blind, randomized, multicenter, placebo-controlled clinical trial","volume":"68","author":"Okubo K","year":"2019","unstructured":"Okubo K, Suzuki T, Tanaka A, Aoki H. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: a double-blind, randomized, multicenter, placebo-controlled clinical trial. Allergol Int. 2019, 68:207-15. 10.1016\/j.alit.2018.08.011","journal-title":"Allergol Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S18265","article-title":"Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial","volume":"4","author":"Marmouz F","year":"2011","unstructured":"Marmouz F, Giralt J, Izquierdo I. Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial. J Asthma Allergy. 2011, 4:27-35. 10.2147\/JAA.S18265","journal-title":"J Asthma Allergy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2003.39.6.799450","article-title":"Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis","volume":"39","author":"Izquierdo I","year":"2003","unstructured":"Izquierdo I, Merlos M, Garc\u00eda-Rafanell J. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. Drugs Today (Barc). 2003, 39:451-68. 10.1358\/dot.2003.39.6.799450","journal-title":"Drugs Today (Barc)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-020-00436-y","article-title":"Towards definitive management of allergic rhinitis: best use of new and established therapies","volume":"16","author":"Hossenbaccus L","year":"2020","unstructured":"Hossenbaccus L, Linton S, Garvey S, Ellis AK. Towards definitive management of allergic rhinitis: best use of new and established therapies. Allergy Asthma Clin Immunol. 2020, 16:10.1186\/s13223-020-00436-y","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091338","article-title":"Platelet-activating factor (PAF) in allergic rhinitis: clinical and therapeutic implications","volume":"8","author":"Mu\u00f1oz-Cano RM","year":"2019","unstructured":"Mu\u00f1oz-Cano RM, Casas-Saucedo R, Valero Santiago A, Bobolea I, Rib\u00f3 P, Mullol J. Platelet-activating factor (PAF) in allergic rhinitis: clinical and therapeutic implications. J Clin Med. 2019, 8:10.3390\/jcm8091338","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2007.01.012","article-title":"Allergic rhinitis and its pharmacology","volume":"114","author":"Al Suleimani YM","year":"2007","unstructured":"Al Suleimani YM, Walker MJ. Allergic rhinitis and its pharmacology. Pharmacol Ther. 2007, 114:233-60. 10.1016\/j.pharmthera.2007.01.012","journal-title":"Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0015.4556","article-title":"A new therapeutic option in the management of allergic rhinitis","volume":"75","author":"Lipiec A","year":"2021","unstructured":"Lipiec A, Jurkiewicz D. A new therapeutic option in the management of allergic rhinitis. Otolaryngol Pol. 2021, 75:1-5. 10.5604\/01.3001.0015.4556","journal-title":"Otolaryngol Pol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397581-olopatadine-vs-rupatadine-for-allergic-rhinitis-a-meta-analysis-of-randomized-controlled-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:08:23Z","timestamp":1755446903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397581-olopatadine-vs-rupatadine-for-allergic-rhinitis-a-meta-analysis-of-randomized-controlled-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.90306","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,17]]}}}